US Patent Issued to Guardant Health on March 4 for "Homologous recombination repair deficiency detection" (California Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,241,126, issued on March 4, was assigned to Guardant Health Inc. (Palo Alto, Calif.).

"Homologous recombination repair deficiency detection" was invented by Jennifer Yen (San Mateo, Calif.), Elena Helman (Redwood City, Calif.) and Arielle Yablonovitch (Belmont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of generating a homologous recombination repair deficiency (HRD) score, determining a reference HRD score, determining a HRD status of a test subject having one or more cancer types, and/or treating a disease based on HRD status. Additional methods as well as related systems, apparatuses, and computer readable media...